Results 261 to 270 of about 140,350 (392)

Incorporating familial risk, lifestyle factors, and pharmacogenomic insights into personalized noncommunicable disease (NCD) reports for healthcare funder beneficiaries participating in the Open Genome Project

open access: yesAnnals of Human Genetics, Volume 89, Issue 4, Page 208-227, July 2025.
Abstract Introduction An ethics‐guided decision‐making framework was developed for applying pathology‐supported genetic testing, a multifaceted pharmacodiagnostic approach that translates population risk stratification into clinical utility. We introduce this service, supported by the Open Genome Project, which aligns with the beneficence principle in ...
Manie De Klerk   +6 more
wiley   +1 more source

Ketotic Hypoglycaemia Following Sleeve Gastrectomy

open access: yesClinical Endocrinology, Volume 103, Issue 1, Page 45-49, July 2025.
ABSTRACT Post‐bariatric surgery hypoglycaemia is typically mediated by hyperinsulinaemia, although the exact mechanisms are incompletely understood. Two cases of non‐insulin mediated, ketotic hypoglycaemia following sleeve gastrectomy are presented. After fasting for 40 and 65 h, respectively, both patients developed symptomatic hypoglycaemia, with ...
Jinwen He   +3 more
wiley   +1 more source

Report on Riboflavin [PDF]

open access: yesJournal of AOAC INTERNATIONAL, 1940
openaire   +2 more sources

The Riboflavin Content of Fresh and Stored Shell Eggs

open access: hybrid, 1952
Robert J. Evans   +2 more
openalex   +1 more source

The influence of the glucagon‐like peptide‐1 receptor agonist, liraglutide, on dietary patterns and nutrient intakes in patients with obesity and prediabetes: A secondary analysis of a randomized controlled trial

open access: yesDiabetes, Obesity and Metabolism, Volume 27, Issue 7, Page 3725-3735, July 2025.
Abstract Aims To evaluate changes in dietary intake following liraglutide treatment, compared to dietitian‐supported caloric restriction and a weight‐neutral control, and to assess dietary intake against nutrition recommendations. Materials and Methods Participants with obesity and prediabetes were randomly assigned 2:1:1 to liraglutide (1.8 mg/day ...
Kelli M. Richardson   +4 more
wiley   +1 more source

Long‐Term Clinical Response to Medical Treatment, Behavioral Therapy, or Their Combination in Cats With Hyperesthesia Syndrome

open access: yesJournal of Veterinary Internal Medicine, Volume 39, Issue 4, July/August 2025.
ABSTRACT Background Hyperesthesia syndrome (HS) is a common yet poorly understood condition in cats, with hypothesized neurological and behavioral causes and limited data on outcomes and treatment. Objectives This study aimed to describe the clinical outcomes and the treatment response of 28 cats with HS, managed through various therapeutic strategies.
Claudia Pauciulo   +6 more
wiley   +1 more source

Supramolecular Gels as Active Tools for Reaction Engineering

open access: yesAngewandte Chemie, Volume 137, Issue 24, June 10, 2025.
The unique combination of environments within gels, self‐assembled from low‐molecular‐weight gelators, offers the ability to control reactivity in new ways, achieving unique reaction outcomes, leading to the emerging concept of supramolecular gels as nanoreactors. Smart chemical engineering methods enable the use of such gels to fabricate materials and
David K. Smith
wiley   +2 more sources

Home - About - Disclaimer - Privacy